HOUSTON -- Treatment with omalizumab (Xolair) was associated with improved endoscopic, clinical, and patient-reported outcomes in two parallel phase III studies in patients with steroid-refractory ...
Please provide your email address to receive an email when new articles are posted on . Patients with nasal polyposis often experience chronic rhinosinusitis, a high symptom burden and poor quality of ...
An indirect treatment comparison shows that dupilumab and tezepelumab yield broadly similar clinical benefits in patients ...
Aside from inhaled and other steroid delivery methods to treat nasal polyps, are any additional medications available? We have a patient who has had 2 operations and is dealing with on-off steroids.
Please provide your email address to receive an email when new articles are posted on . Extended use of omalizumab up to 1 year showed efficacy for the treatment of uncontrolled chronic rhinosinusitis ...
YARDLEY, Pa., June 2, 2021 /PRNewswire/ — Optinose (NASDAQ:OPTN), a global specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and throat (ENT) and allergy ...
1 Add-on maintenance in patients with inadequate response to nasal steroids. 2 Add-on maintenance of chronic rhinosinusitis with nasal polyps (CRSwNP) in patients with inadequate response to nasal ...
(MENAFNEditorial) Nasal polyps are fleshy swellings that tend to develop in the lining of the nose and paranasal sinuses, the air-filled spaces that are linked to the nasal cavity. They are non ...
The FDA expanded the approval of fluticasone propionate (Xhance) nasal spray for chronic rhinosinusitis to also include treatment of adults without nasal polyps, manufacturer Optinose announced on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results